Treatment persistence of biologics among patients with psoriatic arthritis

Treatment persistence of biologics among patients with psoriatic arthritis

Abstract Background Persistence of biologic therapy in psoriatic arthritis (PsA) patients is an important factor in individualized patient treatment planning and healthcare policy and guideline development. Objective To estimate the persistence of biologic agents prescribed to PsA patients in a real...

Full description

Bibliographic Details
Main Authors: Amir Haddad, Tal Gazitt, Ilan Feldhamer, Joy Feld, Arnon Dov Cohen, Idit Lavi, Faten Tatour, Irena Bergman, Devy Zisman
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Arthritis Research & Therapy
Subjects:
Psoriatic arthritis
Drug persistence
Biologics
Online Access:https://doi.org/10.1186/s13075-021-02417-x

Internet

https://doi.org/10.1186/s13075-021-02417-x

Similar Items